Cardiol Therapeutics Inc. Number Of Share Options Granted In Share-based Payment Arrangement
Cardiol Therapeutics Inc. (CRDL) reported Number Of Share Options Granted In Share-based Payment Arrangement of 4.67 million shares for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement · last filed 2026-03-31
USD
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|
| 2022-12-31 | $602.50K 20-F · filed 2023-03-29 |
| 2021-12-31 | $2.67M 20-F · filed 2023-03-29 |
| 2020-12-31 | $1.30M 20-F · filed 2023-03-29 |
shares
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|---|
| 2025-12-31 | 4.67M shares 40-F · filed 2026-03-31 | |
| 2025-01-01 | 1.20M shares 40-F · filed 2025-03-31 | |
| 2024-12-31 | 485.00K shares 40-F · filed 2026-03-31 | |
| 2023-12-31 | 880.00K shares 40-F · filed 2025-03-31 | |
| 2022-12-31 | 602.50K shares 20-F · filed 2024-04-01 | |
| 2021-12-31 | 2.67M shares 20-F · filed 2024-04-01 |